دورية أكاديمية
A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective
| العنوان: | A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective |
|---|---|
| المؤلفون: | Gunda, P, Nikoglou, E, Jugl, SM, Murphy, A |
| المصدر: | Value in Health ; volume 20, issue 9, page A532-A533 ; ISSN 1098-3015 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2017 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Public Health, Environmental and Occupational Health, Health Policy |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.jval.2017.08.758 |
| الإتاحة: | https://doi.org/10.1016/j.jval.2017.08.758Test https://api.elsevier.com/content/article/PII:S1098301517310926?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1098301517310926?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.CD2CE090 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jval.2017.08.758 |
|---|